These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 19015003)

  • 1. Acetyl-L-carnitine provides effective in vivo neuroprotection over 3,4-methylenedioximethamphetamine-induced mitochondrial neurotoxicity in the adolescent rat brain.
    Alves E; Binienda Z; Carvalho F; Alves CJ; Fernandes E; de Lourdes Bastos M; Tavares MA; Summavielle T
    Neuroscience; 2009 Jan; 158(2):514-23. PubMed ID: 19015003
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ecstasy-induced oxidative stress to adolescent rat brain mitochondria in vivo: influence of monoamine oxidase type A.
    Alves E; Summavielle T; Alves CJ; Custódio JB; Fernandes E; de Lourdes Bastos M; Tavares MA; Carvalho F
    Addict Biol; 2009 Apr; 14(2):185-93. PubMed ID: 19076925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A preliminary study on the mechanism of neurotoxicity of MDMA--oxidative stress harm].
    Li SX; Sun AM; Wang X; Li J; Peng ZG; Kuang WH; Huang MS
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Mar; 37(2):191-5. PubMed ID: 16608072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The monoamine oxidase-B inhibitor L-deprenyl protects against 3,4-methylenedioxymethamphetamine-induced lipid peroxidation and long-term serotonergic deficits.
    Sprague JE; Nichols DE
    J Pharmacol Exp Ther; 1995 May; 273(2):667-73. PubMed ID: 7538579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A study of the neurotoxic effect of MDMA ('ecstasy') on 5-HT neurones in the brains of mothers and neonates following administration of the drug during pregnancy.
    Colado MI; O'Shea E; Granados R; Misra A; Murray TK; Green AR
    Br J Pharmacol; 1997 Jun; 121(4):827-33. PubMed ID: 9208155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impaired mitochondrial energy metabolism and neuronal apoptotic cell death after chronic dichlorvos (OP) exposure in rat brain.
    Kaur P; Radotra B; Minz RW; Gill KD
    Neurotoxicology; 2007 Nov; 28(6):1208-19. PubMed ID: 17850875
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
    McNamara R; Kerans A; O'Neill B; Harkin A
    Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phosphodiesterase 5 inhibitors prevent 3,4-methylenedioxymethamphetamine-induced 5-HT deficits in the rat.
    Puerta E; Hervias I; Goñi-Allo B; Lasheras B; Jordan J; Aguirre N
    J Neurochem; 2009 Feb; 108(3):755-66. PubMed ID: 19187094
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Monoamine oxidase-B mediates ecstasy-induced neurotoxic effects to adolescent rat brain mitochondria.
    Alves E; Summavielle T; Alves CJ; Gomes-da-Silva J; Barata JC; Fernandes E; Bastos Mde L; Tavares MA; Carvalho F
    J Neurosci; 2007 Sep; 27(38):10203-10. PubMed ID: 17881526
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risperidone attenuates and reverses hyperthermia induced by 3,4-methylenedioxymethamphetamine (MDMA) in rats.
    Shioda K; Nisijima K; Yoshino T; Kuboshima K; Iwamura T; Yui K; Kato S
    Neurotoxicology; 2008 Nov; 29(6):1030-6. PubMed ID: 18722468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of 3,4-methylenedioxymethamphetamine (MDMA) on serotonin transporter and vesicular monoamine transporter 2 protein and gene expression in rats: implications for MDMA neurotoxicity.
    Biezonski DK; Meyer JS
    J Neurochem; 2010 Feb; 112(4):951-62. PubMed ID: 20002520
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased effects of 3,4-methylenedioxymethamphetamine (ecstasy) in a rat model of depression.
    Jaehne EJ; Majumder I; Salem A; Irvine RJ
    Addict Biol; 2011 Jan; 16(1):7-19. PubMed ID: 20192951
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative effects of 3,4-methylenedioxymethamphetamine and 4-methylthioamphetamine on rat liver mitochondrial function.
    Custódio JB; Santos MS; Gonçalves DI; Moreno AJ; Fernandes E; Bastos ML; Carvalho F; Vicente JA; Fernandes MA
    Toxicology; 2010 Apr; 270(2-3):99-105. PubMed ID: 20138954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of co-administration of 3,4-methylenedioxymethamphetamine ("ecstasy") or para-methoxyamphetamine and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats.
    Stanley N; Salem A; Irvine RJ
    Neuroscience; 2007 Apr; 146(1):321-9. PubMed ID: 17306465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of 3,4-methylenedioxymethamphetamine (MDMA, 'Ecstasy') and para-methoxyamphetamine on striatal 5-HT when co-administered with moclobemide.
    Freezer A; Salem A; Irvine RJ
    Brain Res; 2005 Apr; 1041(1):48-55. PubMed ID: 15804499
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potentiation of 3,4-methylenedioxymethamphetamine-induced 5-HT release in the rat substantia nigra by clorgyline, a monoamine oxidase A inhibitor.
    Hewton R; Salem A; Irvine RJ
    Clin Exp Pharmacol Physiol; 2007 Oct; 34(10):1051-7. PubMed ID: 17714093
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acetyl-L-Carnitine selectively prevents post-ischemic LTP via a possible action on mitochondrial energy metabolism.
    Bagetta V; Barone I; Ghiglieri V; Di Filippo M; Sgobio C; Bernardi G; Calabresi P; Picconi B
    Neuropharmacology; 2008 Aug; 55(2):223-9. PubMed ID: 18590920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pre-treatment with 3,4-methylenedioxymethamphetamine (MDMA) causes long-lasting changes in 5-HT2A receptor-mediated glucose utilization in the rat brain.
    Bull EJ; Porkess V; Rigby M; Hutson PH; Fone KC
    J Psychopharmacol; 2006 Mar; 20(2):272-80. PubMed ID: 16510485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurotoxicity mechanisms of thioether ecstasy metabolites.
    Capela JP; Macedo C; Branco PS; Ferreira LM; Lobo AM; Fernandes E; Remião F; Bastos ML; Dirnagl U; Meisel A; Carvalho F
    Neuroscience; 2007 Jun; 146(4):1743-57. PubMed ID: 17467183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MDMA ('Ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats.
    Clemens KJ; Cornish JL; Li KM; Hunt GE; McGregor IS
    Neuropharmacology; 2005 Aug; 49(2):195-207. PubMed ID: 15993443
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.